As of the public stealth-exit announcement on March 2, 2026, no anchor customer was named in the funding press release or in subsequent coverage from Behavioral Health Business, BusinessWire, or SiliconANGLE. EASE may have signed customers since launch — public information may have moved by the time you read this. The relevant question for facility operators evaluating both platforms today is: which one has a multi-state Joint Commission-accredited provider already running on it in production? That facility is East Point Behavioral Health, and the platform is VProGo.

Yes. The $41M Series A is the single most important market datapoint for the unified behavioral health OS category in 2026. It validates the thesis that an integrated CRM + EHR + RCM + patient engagement + marketing platform is worth building. VProGo agrees with that thesis — that's why VProGo exists. The disagreement is about how to build it. EASE bets on capital and pedigree from a clean slate; VProGo bets on operator-founder fit and shipped product. Both are defensible bets. Different risk profiles for the buyer.

A founder who is also a customer makes different design decisions. The pricing philosophy ("sign a contract because you like us, not because you can't escape") was reactive to the founder reading an executed Dazos contract from a customer's perspective. The multidirectional referral lifecycle was reactive to the founder watching their own admissions team try to use a forward-only sales pipeline. The 8-tier confidence scoring was reactive to the founder watching their own VOB workflow miss money on the table. None of this is theoretical. EASE's leadership team is pedigreed but doesn't have an operating clinic to draw from.

AI-native positioning is a meaningful differentiator if the AI is doing work that materially changes operational outcomes. VProGo uses AI in specific places where it produces measurable value: review eligibility scoring with SI risk detection in VProMove, the standalone Prediction Engine's dynamic confidence weighting, narrative generation in audit reports, and content generation in VProSEO. VProGo is AI-where-AI-helps, not AI-as-architectural-pitch. If EASE's AI-native architecture produces specific operational wins that VProGo doesn't — that's a real comparison. The buyer's question is what specifically and what evidence.

It depends on where you are. For a facility already running on Kipu, Alleva, or another EMR, integration-first eliminates the 6-12 month EMR-replacement project and the staff retraining cost. For a brand-new facility with no existing EMR, all-in-one is a clean slate. Most behavioral health facilities are not brand-new. Most are running an EMR. For that majority, integration-first is materially less disruptive and lands operational value in weeks rather than quarters.

You can. Many facility operators evaluating new platforms in 2026 will wait through one or two product cycles to see what ships. The honest answer is: every quarter you wait is a quarter your facility runs on the existing 7-vendor stack. The opportunity cost of waiting needs to be weighed against the implementation risk of either alternative. VProGo is shipped today. EASE is announced. East Point Behavioral Health did not wait. Your decision is your own.